Annualized return (the real average growth rate each year) to show that the U.S. stock market has been much more profitable in recent decades than over its 155-year history.
NVO's oral Wegovy pill gains FDA approval, a redemption after a 39% 2025 drop. Analysts see potential 33% upside.
IXHL surges 22% on reclassification news, but still down 80% YTD. Tiny $139M cap, a lottery ticket play.
ATAI soars 213% YTD on regulatory wins & strong data; analysts see 190% upside. High risk, high reward!
GDP's hot, but job growth lags! Top 10% boom while others gloom. Traders eye this uneven market.
Manhattan & Queens home prices dip 5% as inventory rises. Sellers adjust to market realities, buyers eye value.
BTC spent <50 days in $70k-$90k bands vs. 200+ days lower. Less support here, traders eye consolidation.
Sponsored
Must Read